Personal tools
Log in

Skip to content. | Skip to navigation

Sections
You are here: Home Newsletter News from G-I-N members SIGN smartphone app
Document Actions
enGINe Newsletter

Subscribe here to the enGINe Newsletter.

Search
Documents in the library
Positronen-Emissions-Tomograph...

IQWiG (DE) - Institute for Quality and Efficiency in Health Care

Positronen-Emissions-Tomographie (PET) bei Ovarialkarzinom

Status:
Published
Date of publication:
Mar 27, 2012
Belimumab - Nutzenbewertung ge...

IQWiG (DE) - Institute for Quality and Efficiency in Health Care

Belimumab - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)

Status:
Published
Date of publication:
Apr 26, 2012
Fampridin - Nutzenbewertung ge...

IQWiG (DE) - Institute for Quality and Efficiency in Health Care

Fampridin - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)

Status:
Published
Date of publication:
Apr 26, 2012
Ipilimumab - Nutzenbewertung g...

IQWiG (DE) - Institute for Quality and Efficiency in Health Care

Ipilimumab - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)

Status:
Published
Date of publication:
Apr 27, 2012
Evidence-based care guideline ...

AHRQ (US) - Agency for Healthcare Research and Quality

Evidence-based care guideline for prevention and management of acute gastroenteritis (AGE) in children aged 2 months to 18 years. Cincinnati Children's Hospital Medical Center. NGC:008846

Status:
Published
Date of publication:
Dec 21, 2011
More guidelines
 

News from members

SIGN guideline recommendations are now be available on the move with the new, free, SIGN app.

SIGN app.jpgDeveloped by the SIGN Executive in collaboration with Root Creative, Glasgow, the app for the Apple iPhone, iPod Touch and iPad launches with quick reference guides (QRG) of these recently published SIGN guidelines:

  • Early rheumatoid arthritis
  • Venous thromboembolism
  • Psoriasis and psoriatic arthritis in adults
  • Chronic venous leg ulcers
  • Stroke: identification and management of dysphagia
  • Stroke: rehabilitation, prevention and management of complications, and discharge planning
  • Management of sore throat and indications for tonsillectomy
  • Diabetes
  • Obesity
  • Non-pharmaceutical management of depression
  • Diagnosis and pharmacological management of Parkinson’s disease.

The QRG content is enhanced with material from the main guideline and online resources, linked to the SIGN website. Each new SIGN QRG will be available as an update through the Apple App Store as it is published, building into a complete library of SIGN QRGs.

This new format will be particularly useful for front line healthcare professionals. The app features keyword search and bookmarking and access to the SIGN website.

New generation smart phones and tablet devices have the usability and straightforward access to content that will provide users with a portable and easily updated means of accessing SIGN guideline material.

The format and content of the QRGs are perfectly suited to the screen size of smart phones and SIGN is now looking at utilising the larger screen of the iPad as a platform for full guidelines.

http://itunes.com/apps/signguidelines

Page last updated: Apr 11, 2011

Bookmark & Share:

  • Facebook
  • Google Bookmarks
  • Twitter

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.